BeiGene
ONC
364.02
+1.24
+0.34%
BeiGene
US · ONC
#538 by market cap
Listed 2016
364.02
+1.24
+0.34%
Live - 5344 symbols - heartbeat 20s ago
· 2026-10-08 05:10
Pre-market
353.40
-2.92%
After-hours
364.16
+0.04%
Overnight
353.82
-2.80%
- Market cap
- 41.39B
- P/E (TTM)i
- 64.43
- P/Bi
- 8.00
- EPSi
- 2.53
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on ONC?
Anonymous reader poll. Unscientific, not investment advice.
About BeiGene
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
- Founded
- 2010
- CEO
- Mr. John V. Oyler
- Employees
- 12,000
- Headquarters
- Basel, Basel-Landschaft (Basle Country), Switzerland
- Fiscal year end
- 12-31
- Website
- beonemedicines.com
Company profile
- Exchange
- US
- Symbol
- ONC
- Market-cap rank
- #538
- Listing date
- 2016-02-03
- Market cap
- 41.39B
- Float cap
- 29.47B
- Shares out
- 113.70M
- Float shares
- 80.95M
Sectors & themes
Quote time 2026-10-08 05:10:03 · For reference only, not investment advice and not tailored to your situation.